Skip to main content

Peer Review reports

From: Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer

Original Submission
10 Nov 2020 Submitted Original manuscript
24 Dec 2020 Author responded Author comments - Qi Zhao
Resubmission - Version 2
24 Dec 2020 Submitted Manuscript version 2
27 Jan 2021 Reviewed Reviewer Report - Paramita Chakraborty
13 Feb 2021 Author responded Author comments - Qi Zhao
Resubmission - Version 3
13 Feb 2021 Submitted Manuscript version 3
28 Mar 2021 Reviewed Reviewer Report
6 May 2021 Author responded Author comments - Qi Zhao
Resubmission - Version 4
6 May 2021 Submitted Manuscript version 4
17 May 2021 Reviewed Reviewer Report
26 May 2021 Author responded Author comments - Qi Zhao
Resubmission - Version 5
26 May 2021 Submitted Manuscript version 5
Publishing
4 Jun 2021 Editorially accepted
30 Jun 2021 Article published 10.1186/s12885-021-08446-8

You can find further information about peer review here.

Back to article page